事業提携・ライセンシング・投資・M&A動向:February 2013(製薬業界)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2013 9
2.2.1 Biogen Idec to Acquire Elan’s Interest in Multiple Sclerosis Drug Tysabri for $3.2 Billion 9
2.2.2 Cardinal Health to Acquire AssuraMed for Up to $2.07 Billion 10
2.2.3 Mylan to Acquire Agila Specialties from Strides Arcolab for Up to $1.85 Billion 10
2.2.4 Quintiles Transnational Files Registration Statement for IPO to Raise Up to $600 Million 10
2.2.5 Chiasma Enters into Licensing Agreement with Roche for Octreolin 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2013 14
3.1.1 Top M&A Deals in February 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2012–February 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2013 17
3.2.1 Top Equity Offering Deals in February 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2012 – February 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2013 20
3.3.1 Top PE/VC Deals in February 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2012 – February 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2012 – February 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2012 – February 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2012 – February 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2012 – February 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2012 – February 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2012 – February 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2013 47
6.2.1 Central Nervous System – Deals of the Month 48
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2013 49
6.3.1 Immunology – Deal of the Month 50
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2013 51
6.4.1 Infectious Diseases – Deals of the Month 52
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2013 53
6.5.1 Metabolic Disorders – Deal of the Month 54
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2013 55
6.6.1 Cardiovascular – Deal of the Month 56
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, February 2013 57
6.7.1 Respiratory – Deal of the Month 58
7 Deal Summary by Geography 59
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2013 59
7.1.1 North America – Deals of the Month 60
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2013 62
7.2.1 Europe – Deals of the Month 63
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2013 65
7.3.1 Asia-Pacific – Deals of the Month 66
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2013 67
7.4.1 Rest of the World – Deals of the Month 68
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 69
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2012 – February 2013 69
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2012 – February 2013 70
9 Further Information 71
9.1 Methodology 71
9.2 About GlobalData 71
9.3 Contact Us 72
9.4 Disclosure information 72
9.5 Disclaimer 72


【レポート販売概要】

■ タイトル:事業提携・ライセンシング・投資・M&A動向:February 2013(製薬業界)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
■ 発行日:2013年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160588
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。